Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Oncology Briefings™: The Evolving Role of IL-1 Inhibitors for Lung Cancer

Release Date: May 29, 2020
Expiration Date: May 29, 2021

Activity Overview

This online activity is designed to provide a concise and focused introduction to interleukin-1 (IL-1) as a therapeutic target in lung cancer, and includes data linking IL-1 inhibition to anticancer activity, as well as ongoing trials examining this potential therapeutic mechanism. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational initiative is directed toward medical oncologists who treat patients with lung cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, fellows, and other health care professionals interested in the treatment of lung cancer will also be invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Consider the role of IL-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice
  • Explain the mechanistic rationale supporting the role of IL-1 inhibitors in the treatment of cancer and subtle mechanistic differences that exist among various IL-1 inhibitors
  • Outline information regarding ongoing and planned trials assessing the efficacy and safety of current and emerging IL-1 inhibitors for the treatment of lung cancer
  • Implement strategies for toxicity management for patients being treated with IL-1 inhibitors

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Edward B. Garon, MD, MS
Edward B. Garon, MD, MS
Professor, Department of Medicine, Division of Hematology/Oncology
Director of Thoracic Oncology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosures: Grant/Research Support: AstraZeneca, Bristol Myers Squibb, Merck, Eli Lilly, Genentech, Novartis, EMD Serono, Iovance, Mirati, Neon, Dynavax; Consultant: Dracen, EMD Serono, Novartis, Glaxo Smith Klein.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By